1. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer
   Benjamin J. Buckley et al, 2018, Journal of Medicinal Chemistry CrossRef